Multicenter Validation Study of a Transplantation-Specific Cytogenetics Grouping Scheme for Patients with Myelodysplastic Syndromes

Cytogenetics are an important prognostic factor for patients with MDS. However, existing cytogenetics grouping schemes are based on patients treated with supportive care, and may not be optimal for patients undergoing allogeneic stem cell transplantation (SCT). We previously proposed an SCT-specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Armand, Philippe, Deeg, H. Joachim, Kim, Haesook T., Lee, Hun, Armistead, Paul, de Lima, Marcos, Gupta, Vikas, Soiffer, Robert J.
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868955/
https://www.ncbi.nlm.nih.gov/pubmed/19784076
http://dx.doi.org/10.1038/bmt.2009.253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868955/
https://www.ncbi.nlm.nih.gov/pubmed/19784076
http://dx.doi.org/10.1038/bmt.2009.253

Ejemplares similares